Security key
G50871105
Jazz Pharmaceuticals plc - Common Stock (JAZZ)
CUSIP: G50871105
Q1 2017 13F Holders as of 31 Mar 2017
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 52,283,523
- Total 13F value
- $7,587,950,162
- Share change
- +3,378,399
- Put/Call ratio
- 72%
- SEC-reported price per share
- $145.13
- Number of holders
- 302
- Value change
- +$512,523,733
- Number of buys
- 138
- Number of sells
- 152
- Shares outstanding
- 61,577,817
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2017
Institutions
302
Top holders
10
JAZZ full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2017
Previous quarter: Q4 2016
Jazz Pharmaceuticals plc SEC filings
Jazz Pharmaceuticals plc company facts
Broader feeds
Reporting periods
Holder history for CUSIP G50871105
Recent filing periods:
Ownership snapshot
Top reported holders of JAZZ - Jazz Pharmaceuticals plc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PUTNAM INVESTMENTS LLC
Disclosed value leader
PUTNAM INVESTMENTS LLC
Comparable rows
15/15
Latest evidence
31 Dec 2016
13F
Lead comparable stake: 12%
Showing 1-6 of 15 holder rows.
Quick read
PUTNAM INVESTMENTS LLC leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PUTNAM INVESTMENTS LLC's linked filing trail.
Comparable ownership
Top 5
PUTNAM INVESTMENTS LLC
12%
FMR LLC
12%
VANGUARD GROUP INC
7.1%
RENAISSANCE TECHNOLOGIES LLC
2.5%
CADIAN CAPITAL MANAGEMENT, LP
2.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PUTNAM INVESTMENTS LLC |
13F
Company
|
12%
|
$836,052,000
7,668,086 shares
|
— | 31 Dec 2016 |
| FMR LLC |
13F
Company
|
12%
|
$813,975,000
7,465,615 shares
|
— | 31 Dec 2016 |
| VANGUARD GROUP INC |
13F
Company
|
7.1%
|
$476,597,000
4,371,250 shares
|
— | 31 Dec 2016 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
2.5%
|
$170,120,000
1,560,300 shares
|
— | 31 Dec 2016 |
| CADIAN CAPITAL MANAGEMENT, LP |
13F
Company
|
2.5%
|
$167,991,000
1,540,782 shares
|
— | 31 Dec 2016 |
| Bank of New York Mellon Corp |
13F
Company
|
2.3%
|
$152,945,000
1,402,787 shares
|
— | 31 Dec 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
302
Shares
52,283,523
Rows available
302
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
287
Q1 2017 holders
302
Holder diff
15
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 value | Q1 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend